Dan Ives, Wedbush Securities global head of tech research, reacts to Apple's earnings report and says AI will be the top story for the company in 2026. Speaking on "Bloomberg Surveillance," Ives also says Apple will probably have to raise iPhone prices. (Source: Bloomberg)
Dan Ives, Wedbush Securities global head of tech research, reacts to Apple's earnings report and says AI will be the top story for the company in 2026. Speaking on "Bloomberg Surveillance," Ives also says Apple will probably have to raise iPhone prices. (Source: Bloomberg)
(RTTNews) - Stock of La Rosa Holdings Corp. (LRHC) are rising about 40 percent during Friday morning trading despite no corporate-related announcements to affect the movement. The company's shares are currently trading at $4.21 on the Nasdaq, up 40.73 percent. The stock opened at $4.24 and has climbed as high as $4.74 so far in today's session. Over the past year, it has traded in a range of $2.83...
(RTTNews) - Stock of La Rosa Holdings Corp. (LRHC) are rising about 40 percent during Friday morning trading despite no corporate-related announcements to affect the movement. The company's shares are currently trading at $4.21 on the Nasdaq, up 40.73 percent. The stock opened at $4.24 and has climbed as high as $4.74 so far in today's session. Over the past year, it has traded in a range of $2.83 to $344.00. LRHC closed trading at $2.99 on Thursday. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
narvo vexar Illumina ( ILMN ) has completed its up to $425M acquisition of proteomics technology company SomaLogic. The deal had Illumina pay $350M upfront with up to $75M more in milestones and royalties. SomaLogic's offerings "provide deep insights into protein function, interactions, and modifications, helping to accelerate understanding of complex biology and human health," per a news release ...
narvo vexar Illumina ( ILMN ) has completed its up to $425M acquisition of proteomics technology company SomaLogic. The deal had Illumina pay $350M upfront with up to $75M more in milestones and royalties. SomaLogic's offerings "provide deep insights into protein function, interactions, and modifications, helping to accelerate understanding of complex biology and human health," per a news release . SomaLogic was part of Standard BioTools ( LAB ). More on Illumina Illumina: What Is Next In This Sequence? Illumina, Inc. (ILMN) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow Illumina, Inc. (ILMN) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript Illumina reports preliminary Q4 revenue of $1.15B Illumina names former NIH official as medical chief; commercial chief joins Quanterix
Oppenheimer Holdings press release ( OPY ): Q4 Non-GAAP EPS of $6.51. Revenue of $472.6M. For the year ended December 31, 2025, the Company reported net income of $148.4 million or $14.13 basic earnings per share compared with net income of $71.6 million or $6.91 basic earnings per share for the year ended December 31, 2024, an increase of 107.4%. Revenue for the year ended December 31, 2025 was $...
Oppenheimer Holdings press release ( OPY ): Q4 Non-GAAP EPS of $6.51. Revenue of $472.6M. For the year ended December 31, 2025, the Company reported net income of $148.4 million or $14.13 basic earnings per share compared with net income of $71.6 million or $6.91 basic earnings per share for the year ended December 31, 2024, an increase of 107.4%. Revenue for the year ended December 31, 2025 was $1.6 billion compared to revenue of $1.4 billion for the year ended December 31, 2024, an increase of 14.4%. More on Oppenheimer Holdings Seeking Alpha’s Quant Rating on Oppenheimer Holdings Dividend scorecard for Oppenheimer Holdings Financial information for Oppenheimer Holdings
This vaccine-focused biotech reported a significant insider sale as it advances its hepatitis B franchise and global partnerships. David Novack, President & COO of Dynavax Technologies Corporation (DVAX +0.07%), exercised 114,000 stock options and immediately sold the resulting shares for a transaction value of approximately $1.8 million, according to the SEC Form 4 filing. Transaction summary Met...
This vaccine-focused biotech reported a significant insider sale as it advances its hepatitis B franchise and global partnerships. David Novack, President & COO of Dynavax Technologies Corporation (DVAX +0.07%), exercised 114,000 stock options and immediately sold the resulting shares for a transaction value of approximately $1.8 million, according to the SEC Form 4 filing. Transaction summary Metric Value Shares sold (direct) 114,000 Transaction value $1.8 million Post-transaction shares (direct) 63,344 Post-transaction value (direct ownership) ~$989,433.28 Key questions How significant was the reduction in David Novack's stake following this transaction? The sale brings his position down to 63,344 shares, which equates to 0.05% of the company's outstanding shares as of Jan. 24, 2026. The sale brings his position down to 63,344 shares, which equates to 0.05% of the company's outstanding shares as of Jan. 24, 2026. What was the derivative context for this transaction? This event involved the exercise of 114,000 stock options, with all resulting shares immediately sold in the open market, reflecting a full conversion from options to common stock without retention of new shares. This event involved the exercise of 114,000 stock options, with all resulting shares immediately sold in the open market, reflecting a full conversion from options to common stock without retention of new shares. How does this transaction compare to Novack's historical trading activity? The size of this exercise and sale substantially exceeded Novack's median sell transaction (30,000 shares in the recent period). The size of this exercise and sale substantially exceeded Novack's median sell transaction (30,000 shares in the recent period). Were any indirect entities or trusts involved in this transaction? All shares were held and transacted directly by Novack; there were no sales or transfers attributed to indirect ownership entities such as family trusts or LLCs. Company overview Metric Value...
Image source: The Motley Fool. Jan. 30, 2026 at 9 a.m. ET Call participants Chief Executive Officer — Thomas Zernick President & Chief Operating Officer — Robin Oliver Chief Financial Officer — Scott McKim Takeaways Net loss -- $2.5 million for the quarter, a smaller loss than the $18.9 million reported in the previous quarter, which included large restructuring and provision expenses. -- $2.5 mil...
Image source: The Motley Fool. Jan. 30, 2026 at 9 a.m. ET Call participants Chief Executive Officer — Thomas Zernick President & Chief Operating Officer — Robin Oliver Chief Financial Officer — Scott McKim Takeaways Net loss -- $2.5 million for the quarter, a smaller loss than the $18.9 million reported in the previous quarter, which included large restructuring and provision expenses. -- $2.5 million for the quarter, a smaller loss than the $18.9 million reported in the previous quarter, which included large restructuring and provision expenses. Deposit growth -- Deposits increased $12.5 million in the quarter and $40.7 million, or 3.6%, for the year, reaching $1.18 billion. -- Deposits increased $12.5 million in the quarter and $40.7 million, or 3.6%, for the year, reaching $1.18 billion. Insured deposits -- 85% of total deposits are FDIC-insured as of December 31, supporting perceived deposit stability. -- 85% of total deposits are FDIC-insured as of December 31, supporting perceived deposit stability. Loan balances -- Total loans held for investment decreased $34.8 million in the quarter and $102.7 million, or 9.6%, over the year to $963.9 million, reflecting strategic actions including exits and sales. -- Total loans held for investment decreased $34.8 million in the quarter and $102.7 million, or 9.6%, over the year to $963.9 million, reflecting strategic actions including exits and sales. Unguaranteed SBA 7(a) loans -- Portfolio reduced by $50.4 million sequentially to $171.6 million at quarter-end, with ongoing sales and runoff expected. -- Portfolio reduced by $50.4 million sequentially to $171.6 million at quarter-end, with ongoing sales and runoff expected. Net interest margin -- 3.58%, down three basis points from the previous quarter. -- 3.58%, down three basis points from the previous quarter. Provision for credit losses -- $2 million in the fourth quarter, versus $10.9 million in the third quarter; elevated due to SBA 7(a) exposure. -- $2 million in t...
A detail view of the Super Bowl LX logo on a Santa Clara Valley Transportation Authority (VTA) light rail car on December 29, 2025 in Santa Clara, California. Aaron M. Sprecher | Getty Images Sport | Getty Images A version of this article first appeared in the CNBC Sport newsletter with Alex Sherman, which brings you the biggest news and exclusive interviews from the worlds of sports business and ...
A detail view of the Super Bowl LX logo on a Santa Clara Valley Transportation Authority (VTA) light rail car on December 29, 2025 in Santa Clara, California. Aaron M. Sprecher | Getty Images Sport | Getty Images A version of this article first appeared in the CNBC Sport newsletter with Alex Sherman, which brings you the biggest news and exclusive interviews from the worlds of sports business and media. Sign up to receive future editions, straight to your inbox. For many Americans, the best part of the Super Bowl is the commercials. This year, you can make — or lose — money on them, too. Prediction market platforms Kalshi and Polymarket currently have contracts open on which companies will run ads during Super Bowl 60, set for Feb. 8 in Santa Clara, California. Users can trade on if Salesforce or Verizon or Coca-Cola will have a Super Bowl spot this year, for example. While Polymarket's trades are just a "Yes/No" bet, Kalshi has a few predictions that are a bit more nuanced, such as, "Who will appear in a big game ad before Feb 9, 2026?", with trades available for Sydney Sweeney, Timothée Chalamet and Harry Styles. It's a new wrinkle for the advertising industry's biggest night. The price of Super Bowl commercials goes higher and higher each year as the Super Bowl's TV audience keeps rising. Last year's game was watched by 127.7 million viewers, a record high . That game, broadcast by Fox, generated about $7.5 million per 30-second spot, with 10 or so ads commanding more than $8 million. This year, NBC has sold out all of its ad inventory averaging $8 million per 30-second commercial with between five and 10 ads selling for more than $10 million apiece, according to NBC Chairman of Global Advertising and Partnerships Mark Marshall. The closer to the game that a company buys an ad slot, the more it pays. According to Marshall, technology companies have bought the most spots across this year's slate, though NBC defines technology relatively broadly. (Uber Eats, for ex...
Hi, it’s Swetha Gopinath in London, where I spoke with a top private equity executive at I Squared about how the firm is carving out a niche for itself as a mid-market infra investment manager. Elsewhere, Elon Musk weighs how to consolidate his empire. Today’s top stories Musk’s SpaceX considers merging with Tesla or xAI. Coterra and Devon are in advanced talks on merger. Abu Dhabi folds ADQ under...
Hi, it’s Swetha Gopinath in London, where I spoke with a top private equity executive at I Squared about how the firm is carving out a niche for itself as a mid-market infra investment manager. Elsewhere, Elon Musk weighs how to consolidate his empire. Today’s top stories Musk’s SpaceX considers merging with Tesla or xAI. Coterra and Devon are in advanced talks on merger. Abu Dhabi folds ADQ under new entity L’imad in shakeup . Amazon in talks to invest $50 billion in OpenAI, expand ties. Bertelsmann considers acquisition of Concord Music. AI adjacent The AI surge has turned data centers into one of the fastest-growing investment areas globally. Mid-market infrastructure specialist I Squared is taking a nuanced approach to the boom, opting to put money into AI-adjacent projects. I sat down with Mohamed El Gazzar, a senior partner at the firm, to talk about this strategy and the broader case for infra investing in 2026. Here are some edited highlights from our chat. —Swetha Gopinath Your firm has been wary of jumping on the AI bandwagon, would you still invest in data centers? We don’t have anything against AI, it just goes back to how cautious of an investor we are. In AI investing, attention is often focused on the data centers and chips, but the underlying infrastructure and power are just as critical, and where we have deep expertise. We understand the power market and the bottlenecks that exist for data centers, and this is exactly what we demonstrated with Energia. We developed a 165-megawatt data center co-located with our gas-powered plants in Dublin, navigating a complex planning and permitting process. We partnered with a hyperscale operator and secured a contract with Microsoft. Ultimately, we sold Energia alongside one of Europe’s largest data centers, demonstrating how we can selectively participate in AI-adjacent opportunities without chasing it directly. Is it more difficult to invest in the AI space in Europe? In the US, data centers tend to be very l...
Inok Gold ( XAUUSD:CUR ) and silver ( XAGUSD:CUR ) mining and spot-based exchange traded funds are under notable pressure Friday morning as precious metals retraced sharply following a powerful recent rally. Gold prices are down roughly 6%, and are looking to stabilize just above $5,000 per ounce after briefly surging past $5,500 earlier in the week. Silver has experienced an even steeper pullback...
Inok Gold ( XAUUSD:CUR ) and silver ( XAGUSD:CUR ) mining and spot-based exchange traded funds are under notable pressure Friday morning as precious metals retraced sharply following a powerful recent rally. Gold prices are down roughly 6%, and are looking to stabilize just above $5,000 per ounce after briefly surging past $5,500 earlier in the week. Silver has experienced an even steeper pullback, sliding approximately 15% to fall back below $100 per ounce after spiking above $120 only days ago. The swift reversal has shifted market attention toward vehicles tracking the metals directly, as well as companies exposed to their production. Spot gold and silver ETFs have moved decisively lower, while mining-focused funds are also posting substantial losses as trading begins. The selloff reflects a combination of profit-taking after outsized gains and heightened short-term volatility across commodity markets. Despite the abrupt move, prices for both metals remain well above levels seen earlier this year, underscoring the magnitude of the prior advance. Investors are now assessing whether the decline represents a healthy consolidation within a broader bullish trend or the early stages of a more sustained correction. Gold and Gold Mining ETFs: ( GLD ), ( IAU ), ( SGOL ), ( OUNZ ), ( BAR ), ( GDX ), ( GDXJ ), ( NUGT ), ( RING ), and ( DUST ). Silver and Silver Mining ETFs: ( SLV ), ( SIVR ), ( AGQ ), ( ZSL ), ( PSLV ), ( SIL ), ( SILJ ), and ( SLVP ). More on markets Is Kevin Warsh really a Hawk? TS Lombard’s Perkins says the label no longer fits January crossroads: Can the S&P 500 extend its three-year winning streak? Trump talks up the dollar as DXY sinks to its lowest level in nearly four years Oppenheimer sees strong start to earnings season as it favors growth sectors Dividend Roundup: Wells Fargo, General Motors, Citigroup, Comcast, and more
David Petrus Ibars/E+ via Getty Images Investment Thesis I recommend buying the Roundhill GLP-1 & Weight Loss ETF (NASDAQ: OZEM ). This is my first article about a thematic ETF of this type. However some time ago I wrote my investment thesis about Eli Lilly, and the company was part of my recommended stock portfolio for 2025. In this article my intention is to analyze the characteristics of OZEM, ...
David Petrus Ibars/E+ via Getty Images Investment Thesis I recommend buying the Roundhill GLP-1 & Weight Loss ETF (NASDAQ: OZEM ). This is my first article about a thematic ETF of this type. However some time ago I wrote my investment thesis about Eli Lilly, and the company was part of my recommended stock portfolio for 2025. In this article my intention is to analyze the characteristics of OZEM, in addition to analyzing the growth of the sector and the true catalyst that makes the thesis so attractive in my opinion. Context On September 4, I wrote an article about Eli Lilly. The title of the article was: Eli Lilly's Stock Fall Is An Opportunity. Since then, the total return is 39.25% while the S&P 500 is 8.08%. I was so convinced of the company's thesis that it was even part of my recommended stock portfolio in 2025, which even handily beat the S&P 500. My Recommendation (The Author) For 2026, I made adjustments to my recommended stock portfolio and included a mix of American stocks with Brazilian stocks, aiming for a higher dividend payment and exposure to emerging markets with cheap valuations. Therefore, Eli Lilly left my portfolio. Another major issue in the investment thesis is that Eli Lilly, despite being in an extremely promising sector, had a much higher valuation than its competitors. All of these questions made me look for a new way of gaining exposure to the weight loss drug industry. Therefore, today, I'm going to talk about OZEM. Roundhill GLP-1 & Weight Loss ETF If you have ever wondered which is the best pharmaceutical company to invest in, be it the owner of Mounjaro or the owner of Ozempic or any other pharmaceutical company with weight loss drugs, the ETF I will mention will probably solve your problem. Today I'm going to talk about OZEM. It is managed by Roundhill Investments and was created in 2024. It currently has $58 million in AUM and an expense ratio of 0.59%. Its main position is Novo Nordisk with 22.59%, its second largest position is El...
guirong hao/iStock via Getty Images Over the last few years, I’ve covered shares of Rocket Lab Corporation ( RKLB ) five times, rating the stock a Strong Buy or Buy each time: Seeking Alpha Those who have followed my bullish ratings have done quite well, with shares appreciating more than 1,400% since my first article: TradingView Rocket Lab - as a company - has performed spectacularly over this s...
guirong hao/iStock via Getty Images Over the last few years, I’ve covered shares of Rocket Lab Corporation ( RKLB ) five times, rating the stock a Strong Buy or Buy each time: Seeking Alpha Those who have followed my bullish ratings have done quite well, with shares appreciating more than 1,400% since my first article: TradingView Rocket Lab - as a company - has performed spectacularly over this span. The company’s launch business has grown and become one of the most credible in the industry, and the firm's space systems segment has structurally transformed RKLB into a high-growth business with embedded operating leverage. As the model evolves, the launch segment promises to act as a strategic enabler for the company’s space systems business, which could drive meaningful long-tail shareholder value. As it turns out, being a vertically integrated space company can be highly lucrative. However, since I first covered the stock, shares of RKLB have increased in price from roughly 10x sales to over 80x sales. Obviously, some part of this reflects a broader market understanding of Rocket Lab’s true opportunity. That said, the price has now reached a point where I no longer believe buying shares is the best way to profit from the company. Selling put options on RKLB, which offer a better entry point (if assigned) while paying out a robust cash-on-cash yield, appears to be a much better risk-reward play. In this article, I’ll cover recent developments at Rocket Lab, highlight my concerns about the valuation, and make the case that selling put options on RKLB is a more optimal way to deploy capital than buying new shares outright. Sound good? Let’s dive in. Financials Let’s start by taking a quick look at the company’s financials. I haven’t covered Rocket Lab since July of last year, so it makes sense to update readers on my view. In short, RKLB is still firing on all cylinders . In Q3, the company reported revenue of $155 million, up 48% year over year, marking a new quarte...
In this podcast, Motley Fool contributors Tyler Crowe, Matt Frankel, and Jon Quast discuss: Rocket Lab 's test failure. 's test failure. SpaceX's IPO rumors and who could quickly follow. Investing advice when analyzing IPOs. Potential IPOs on their radar. To catch full episodes of all The Motley Fool's free podcasts, check out our podcast center. When you're ready to invest, check out this top 10 ...
In this podcast, Motley Fool contributors Tyler Crowe, Matt Frankel, and Jon Quast discuss: Rocket Lab 's test failure. 's test failure. SpaceX's IPO rumors and who could quickly follow. Investing advice when analyzing IPOs. Potential IPOs on their radar. To catch full episodes of all The Motley Fool's free podcasts, check out our podcast center. When you're ready to invest, check out this top 10 list of stocks to buy. Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Continue » A full transcript is below. Should you buy stock in Rocket Lab right now? Before you buy stock in Rocket Lab, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Rocket Lab wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $448,476!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,180,126!* Now, it’s worth noting Stock Advisor’s total average return is 945% — a market-crushing outperformance compared to 197% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors. See the 10 stocks » *Stock Advisor returns as of January 30, 2026. This podcast was recorded on Jan. 22, 2026. Tyler Crowe: The 2026 IPO market looks like it's about to blast off. This is Motley Fool Money. Welcome to Motley Fool Money. I'm Tyler Crowe, and today I'm joined by longtime fool contributors, Matt Frankel and Jon Quast. We're going to get into the 2026 IPO market because there's been quite a bit of chatter in this past week out of who's going public, what companies we could expect to see this...
Banco Santander-Chile press release ( BSAC ): FY Non-GAAP EPS of $2.48. As of December 31, 2025, the Bank had total assets of $68,094,956 million (US$75,603 million), total gross loans (including interbank loans) at amortized cost of $40,932,880 million (US$45,446 million), total deposits of $30,569,372 million (US$33,940 million), and shareholders' equity of $4,719,697 million (US$5,240 million)....
Banco Santander-Chile press release ( BSAC ): FY Non-GAAP EPS of $2.48. As of December 31, 2025, the Bank had total assets of $68,094,956 million (US$75,603 million), total gross loans (including interbank loans) at amortized cost of $40,932,880 million (US$45,446 million), total deposits of $30,569,372 million (US$33,940 million), and shareholders' equity of $4,719,697 million (US$5,240 million). The BIS capital ratio was 16.9%, with a core capital ratio of 11.0%. As of December 31, 2025, Santander Chile employed 8,526 people and had 229 branches throughout Chile . More on Banco Santander-Chile Banco Santander-Chile 2025 Q3 - Results - Earnings Call Presentation Banco Santander-Chile (BSAC) Q3 2025 Earnings Call Transcript Seeking Alpha’s Quant Rating on Banco Santander-Chile Historical earnings data for Banco Santander-Chile Dividend scorecard for Banco Santander-Chile
Image source: The Motley Fool. Friday, January 30, 2026 at 9 a.m. ET CALL PARTICIPANTS Chief Executive Officer — Palmer Proctor Chief Financial Officer — Nicole S. Stokes Operator Need a quote from a Motley Fool analyst? Email [email protected] TAKEAWAYS Full-Year Net Income -- $412.2 million, with diluted EPS at $6, representing a 15% increase. -- $412.2 million, with diluted EPS at $6, represent...
Image source: The Motley Fool. Friday, January 30, 2026 at 9 a.m. ET CALL PARTICIPANTS Chief Executive Officer — Palmer Proctor Chief Financial Officer — Nicole S. Stokes Operator Need a quote from a Motley Fool analyst? Email [email protected] TAKEAWAYS Full-Year Net Income -- $412.2 million, with diluted EPS at $6, representing a 15% increase. -- $412.2 million, with diluted EPS at $6, representing a 15% increase. Fourth-Quarter Net Income -- $108.4 million, or $1.59 per diluted share. -- $108.4 million, or $1.59 per diluted share. Net Interest Margin -- Expanded five basis points sequentially to 3.85% for the fourth quarter, primarily driven by a 10 basis point positive impact on funding and partially offset by a five basis point decline on the asset side. -- Expanded five basis points sequentially to 3.85% for the fourth quarter, primarily driven by a 10 basis point positive impact on funding and partially offset by a five basis point decline on the asset side. Net Interest Income Growth -- Increased $7.3 million in the quarter (12.2% annualized), with a full-year increase of $87.7 million, or 10.3%. -- Increased $7.3 million in the quarter (12.2% annualized), with a full-year increase of $87.7 million, or 10.3%. Efficiency Ratio -- Improved to 46.6% in the fourth quarter and was 50% for the year, down from 53.2% last year. -- Improved to 46.6% in the fourth quarter and was 50% for the year, down from 53.2% last year. Tangible Book Value Per Share -- Increased by $1.28 in the fourth quarter to $44.18; full-year growth was $5.59 per share, or 14.5%. -- Increased by $1.28 in the fourth quarter to $44.18; full-year growth was $5.59 per share, or 14.5%. Return on Assets (ROA) -- 1.57% for the quarter and 1.54% for the year, up from 1.38% last year. -- 1.57% for the quarter and 1.54% for the year, up from 1.38% last year. Pre-Provision Net Revenue (PPNR) ROA -- 2.38% for the quarter; full-year was 2.25%, up from 2.05% last year. -- 2.38% for the quarter; full-year wa...
Tesla Inc. (NASDAQ:TSLA) CEO Elon Musk has shared that the company would need to scale up its "TeraFab" in-house chip-building efforts amid an AI push during its earnings call. Chips Are The ‘Limiting Factor' For Tesla's Growth On Wednesday, Musk was asked about Tesla's chip-building efforts during the earnings conference. Musk said that the AI5 Chip design was currently "the number one most criti...
Tesla Inc. (NASDAQ:TSLA) CEO Elon Musk has shared that the company would need to scale up its "TeraFab" in-house chip-building efforts amid an AI push during its earnings call. Chips Are The ‘Limiting Factor' For Tesla's Growth On Wednesday, Musk was asked about Tesla's chip-building efforts during the earnings conference. Musk said that the AI5 Chip design was currently "the number one most critical thing to get done." However, he said that chip production remains a "limiting factor for Tesla's growth" in the next "three or four years." "I think Tesla needs to build a TeraFab," Musk said, adding that the "geopolitical risks" were going to be a major factor in the near future. "I think if we don’t do the Tesla TeraFab, we’re going to be limited by supplier output of chips," Musk said. The CEO also shared that there would be a "bigger announcement" on TeraFab by Tesla in the future. Don't Miss: Missed Nvidia and Tesla? RAD Intel Could Be the Next AI Powerhouse — Just $0.85 a Share If there was a new fund backed by Jeff Bezos offering a 7-9% target yield with monthly dividends would you invest in it? Tesla's 2nm Chip Ambitions The news comes as Musk had earlier shared that Tesla would be developing its own 2nm chip amid a push towards in-house chip-making efforts. Musk had also shared that Tesla would manufacture more chips than any of its other competitors. Musk also claimed that Tesla's fabrication process would enable him to eat a cheeseburger and smoke a cigar in the Clean Room, unlike other fabs, due to "wafer isolation." A clean room is a highly controlled environment in chip foundries that allows only ultra-low levels of airborne particles, humidity, and other contaminants that could contaminate chipsets. The company also announced a $2 billion investment in Musk’s artificial intelligence startup, xAI. See Also: Blue-chip art has historically outpaced the S&P 500 since 1995, and fractional investing is now opening this institutional asset class to everyday inve...
LD Prediction markets are still open for business on who Donald Trump might tap as the next chair of the Federal Reserve, even as the U.S. President has selected Kevin Warsh to take the helm. Even as traditional political analysis narrows the field, platforms such as Kalshi and Polymarket continue to take wagers, turning the nomination process into a tradeable event. The logic is familiar to anyon...
LD Prediction markets are still open for business on who Donald Trump might tap as the next chair of the Federal Reserve, even as the U.S. President has selected Kevin Warsh to take the helm. Even as traditional political analysis narrows the field, platforms such as Kalshi and Polymarket continue to take wagers, turning the nomination process into a tradeable event. The logic is familiar to anyone who follows merger arbitrage. Traders buy shares of an acquisition target not because they love the company, but because they expect to earn small, steady gains as the deal inches toward completion. The real money, however, comes from tail risks. If a deal collapses, prices can swing sharply. Fed chair betting works the same way. Most contracts cluster around a handful of names, including former Fed governor Warsh. Prediction market Kalshi said a nomination is valid only when it is formally transmitted to and received by the U.S. Senate, and Polymarket stuck to a similar note. Polymarket showed a 99.4% chance of Warsh being Trump's nominee, while others like Judy Shelton, Michelle Bowman, and Kevin Hassett have under a 1% chance. On Kalshi, the odds are not much different, with Warsh at 98% Shelton and Rick Rieder at 1% each. Warsh, if confirmed, would become the 17th Fed chair. He served as the Fed governor from February 2006 to March 2011. More on markets My Hot Take On Kevin Warsh's Nomination An Uncertain But Positive Fed Supports Commodity Rally A Diversified Portfolio Should Outperform The Magnificent 7 This Year Top 3 things to look forward to on Friday U.S. stocks end mixed, MSFT sees one of its worst sell-off days as big tech earnings fail to lift sentiments
SM Energy ( SM ) on Friday said that it has amended its existing credit facility, increasing its borrowing base to $5.0 billion and lender commitments to $2.5 billion. The amendment also expands the company’s bank group to 18 lenders with the addition of three banks and extends the facility’s maturity date to January 30, 2031. The company said it had no outstanding borrowings under the credit faci...
SM Energy ( SM ) on Friday said that it has amended its existing credit facility, increasing its borrowing base to $5.0 billion and lender commitments to $2.5 billion. The amendment also expands the company’s bank group to 18 lenders with the addition of three banks and extends the facility’s maturity date to January 30, 2031. The company said it had no outstanding borrowings under the credit facility at closing. SM -0.52% premarket to $18.77. Source: Press Release More on SM Energy Civitas Resources: Upgrading To Buy On Transformational Merger With SM Energy SM Energy Company (SM) Presents at Bank of America Leveraged Finance Conference Transcript SM Energy And Civitas Resources Merger: Don't Judge A Book By Its Cover Key deals this week: ITV-Sky, Metsera, Kyndryl, SM Energy, KNOT Offshore, Sonida Senior and more SM Energy Q3 2025 Earnings Preview
In this week's Club Check-in, Paulina Likos and Zev Fima break down the uncertainty surrounding the Federal Reserve as markets approach a pivotal transition in May, when a new Fed chair is expected to be appointed, and assess how Club members should be thinking about their investments. Multiple developments have raised questions about the future of the Federal Reserve's independence, including Pre...
In this week's Club Check-in, Paulina Likos and Zev Fima break down the uncertainty surrounding the Federal Reserve as markets approach a pivotal transition in May, when a new Fed chair is expected to be appointed, and assess how Club members should be thinking about their investments. Multiple developments have raised questions about the future of the Federal Reserve's independence, including President Donald Trump 's public calls for lower interest rates, a Justice Department probe into current central bank chief Jerome Powell , and a Supreme Court case involving the president's attempt to fire Fed governor Lisa Cook. Perhaps Trump's announcement Friday morning of Kevin Warsh — a former Fed governor — to succeed Powell as Fed chairman will ease some of those concerns because Warsh is perceived to be more hawkish than the other candidates. Either way, the new Fed leader will need to reconcile the president's desire for rate cuts and a stabilizing economy that might not need more easing. In fact, following its two-day January meeting, the Fed on Wednesday afternoon held interest rates steady. Powell said the economy was in a good place for central bankers to wait for more economic data to determine their next move. The Fed has cut rates a total of 175 basis points in three moves at the end of 2024 and three more at the end of last year. Powell, whose term leading the Fed ends in May, defended central bank independence as a cornerstone of modern democracies to prevent "elected official control over the setting of monetary policy." The key for investors in this upcoming time of uncertainty is to consider a diversification of outcomes when it comes to managing their portfolios. In the video, we talk about the Club approach . (See here for a full list of the stocks in Jim Cramer's Charitable Trust.) As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade. Jim waits 45 minutes after sending a trade alert before ...